.Turnstone Biologics is actually reducing its own head count through 60% and agitating its C-suite i...
.In a year that has seen an approval and a plethora of readouts for metabolic dysfunction-associated...
.Alaunos Therapies is axing an arrangement with Precigen, losing hope licensing legal rights to a ta...
.Capricor Rehabs is actually taking a success lap for their stage 2 Duchenne muscle dystrophy (DMD) ...
.The FDA has positioned Kezar Lifestyle Sciences' lupus trial on grip after the biotech flagged 4 de...
.A period 3 trial of Historian Rock's spinal muscular degeneration (SMA) applicant has actually hit ...
.RNA biotech CAMP4 Therapies has actually defined plans for a $67 million IPO, along with inflammati...
.A year after the failure of an idiopathic pulmonary fibrosis candidate delivered Galecto on a seek ...
.Taking the floor covering is Judo Biography, an up-and-coming biotech armed along with $one hundred...
.AstraZeneca has paid CSPC Pharmaceutical Team $100 million for a preclinical heart attack medicatio...